1. Home
  2. CASI vs TPIC Comparison

CASI vs TPIC Comparison

Compare CASI & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • TPIC
  • Stock Information
  • Founded
  • CASI 1991
  • TPIC 1968
  • Country
  • CASI China
  • TPIC United States
  • Employees
  • CASI N/A
  • TPIC N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • TPIC Industrial Machinery/Components
  • Sector
  • CASI Health Care
  • TPIC Industrials
  • Exchange
  • CASI Nasdaq
  • TPIC Nasdaq
  • Market Cap
  • CASI 31.0M
  • TPIC 35.5M
  • IPO Year
  • CASI 1996
  • TPIC 2016
  • Fundamental
  • Price
  • CASI $1.89
  • TPIC $0.87
  • Analyst Decision
  • CASI Strong Buy
  • TPIC Hold
  • Analyst Count
  • CASI 1
  • TPIC 6
  • Target Price
  • CASI $4.00
  • TPIC $1.86
  • AVG Volume (30 Days)
  • CASI 8.4K
  • TPIC 337.8K
  • Earning Date
  • CASI 05-20-2025
  • TPIC 05-12-2025
  • Dividend Yield
  • CASI N/A
  • TPIC N/A
  • EPS Growth
  • CASI N/A
  • TPIC N/A
  • EPS
  • CASI N/A
  • TPIC N/A
  • Revenue
  • CASI $28,537,000.00
  • TPIC $1,331,131,000.00
  • Revenue This Year
  • CASI N/A
  • TPIC $8.85
  • Revenue Next Year
  • CASI N/A
  • TPIC $7.52
  • P/E Ratio
  • CASI N/A
  • TPIC N/A
  • Revenue Growth
  • CASI N/A
  • TPIC N/A
  • 52 Week Low
  • CASI $1.64
  • TPIC $0.64
  • 52 Week High
  • CASI $7.67
  • TPIC $5.75
  • Technical
  • Relative Strength Index (RSI)
  • CASI 44.54
  • TPIC 47.43
  • Support Level
  • CASI $1.64
  • TPIC $0.93
  • Resistance Level
  • CASI $1.94
  • TPIC $1.04
  • Average True Range (ATR)
  • CASI 0.09
  • TPIC 0.09
  • MACD
  • CASI -0.00
  • TPIC 0.02
  • Stochastic Oscillator
  • CASI 55.77
  • TPIC 46.71

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About TPIC TPI Composites Inc.

TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.

Share on Social Networks: